Do Drug Accessibility and OOP Burden Affect Health-Related Quality of Life of Patients With Chronic Diseases? — EQ-5D-5L Evaluation Evidence From Five Districts in China

Frontiers in Public Health

Kean Tang¹  Duoer Yang²  Shaoliang Tang³  Meixian Liu³  Ying Gong³ 

[1] Faculty of Science, Lund University, Lund, Sweden;Nanjing Stomatological Hospital, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China;School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China;

关键词: patients with chronic diseases;    health-related quality of life;    drug accessibility;    OOP;    CLAD model;   

DOI  :  10.3389/fpubh.2021.656104

来源: Frontiers

【 授权许可】

CC BY